Lululemon reported first-quarter revenue of $2.21 billion, beating the consensus estimate of $2.2 billion, according to Benzinga Pro. The athleisure company reported quarterly earnings of $2.54 per share, beating analyst estimates of $2.39 per share.
Dutch Bros (NYSE: BROS) shares are trading higher Wednesday afternoon. The company received a positive outlook from TD Cowen, which reiterated its Buy rating and maintained a $46 price target.
FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit, with CYBN, MNMD, and ATAI down. FDA not bound by decision.
Analyst initiates coverage on Proto Labs with Overweight rating and $44.00 price target. Company well-positioned in growing digital manufacturing market.
Madrigal Pharmaceuticals and Sagimet Biosciences shares fall following Eli Lilly's presentation at the EASL Liver Congress 2024. Phase 2 tirzepatide trial shows promising results for MASH treatment. Further trials needed to confirm efficacy and safety.
Over the past 24 hours, Monero's (CRYPTO: XMR) price rose 3.72% to $164.18. This continues its positive trend over the past week where it has experienced a 17.0% gain, moving from $140.62 to its current price. As it stands right now, the coin's all-time high is $542.33.
FLOKI's (CRYPTO: FLOKI) price has increased 6.3% over the past 24 hours to $0.00031. Over the past week, FLOKI has experienced an uptick of over 16.0%, moving from $0.00027 to its current price.